Investigational Drug Abaloparatide Reduces the Incidence of Fractures in Postmenopausal Women With Osteoporosis
Go back to Investigational Drug Abaloparatide Reduces the Incidence of Fractures in Postmenopausal Women With Osteoporosis| (NASDAQ: RDUS) | Delayed: 30.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.00 | 52 Week High | $75.47 | |||
| Open | $30.00 | 52 Week Low | $24.75 | |||
| Day High | $30.00 | P/E | N/A | |||
| Day Low | $30.00 | EPS | $0.00 | |||
| Volume | 952 | |||||
